CCL2 and neoplasm: Microarray analysis of the tumors revealed that targeting STAT3 increased the expression of multiple chemokines, such as CCL2, CCL9, CCL12, CCL17, and CCL21c, and induced downregulation of MHC class I molecules H2-D1 and H2-K1 in the tumor cells.